Skip to main content
. 2019 Feb 6;10(2):535–547. doi: 10.1007/s13300-019-0578-6

Table 8.

Different stage comparison of HOMA-S before and after ABM-MNC therapy

Items (months) Test for heterogeneity Analysis model Test for overall effect WMD or SMD 95% CI
I2 (%) P Z P
3 0 0.36 Fixed 0.49 0.62 9.75 (− 28.96, 48.47)
6 0 0.97 Fixed 0.75 0.46 14.82 (− 24.12, 53.77)